Lexeo Therapeutics, Inc.

LXEO·NASDAQ·$5.14Share Price as of 11/2·$404MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report09/29/26 8-KCurrent report09/22/26 8-KCurrent report08/12/26 8-KCurrent report06/29/26 8-KCurrent report06/15/26

Prospectuses and Registrations

S-3Shelf registration10/29/26 S-8Registration of securities for employees03/30/26 424B3Prospectus11/26/25 S-3Shelf registration11/05/25 S-8Registration of securities for employees11/05/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEFA14AAdditional proxy materials06/05/25 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25

Ownership

SC 13GBeneficial ownership10/13/26 Form 4Insider transaction09/28/26 Form 4Insider transaction09/28/26 Form 4Insider transaction09/28/26 Form 4Insider transaction09/28/26

Other

ARSAnnual report to shareholders04/30/26 EFFECTRequest for effectiveness11/26/25 CORRESPCorrespondence with the SEC11/25/25 EFFECTRequest for effectiveness06/30/25 CORRESPCorrespondence with the SEC06/27/25